Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inbal Houri

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Transplantation|September 10, 2021
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccineAyelet Grupper, Eugene Katchman, Merav Ben-Yehoyada, et al.
Transplantation Proceedings|March 29, 2022
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsAyelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, et al.
Elife|January 27, 2023
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional studyAvner Ehrlich, Konstantinos Ioannidis, Makram Nasar, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Transplantation|September 10, 2021
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccineAyelet Grupper, Eugene Katchman, Merav Ben-Yehoyada, et al.
Transplantation Proceedings|March 29, 2022
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsAyelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, et al.
Elife|January 27, 2023
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional studyAvner Ehrlich, Konstantinos Ioannidis, Makram Nasar, et al.
Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.
Pageof 2